Administration of kisspeptin-54 into discrete regions of the hypothalamus potently increases plasma luteinising hormone and testosterone in male adult rats.
Patterson. M M; Murphy. K G KG; Thompson. E L EL; Patel. S S; Ghatei. M A MA; Bloom. S R SR
Key Findings
- Kisspeptin‑54 injected into the medial preoptic area (MPOA) at doses of 1 pmol or higher raised LH and testosterone after 60 minutes.
- A single low dose (1 pmol) delivered to several hypothalamic nuclei (RPOA, MPOA, PVN, arcuate) also boosted LH and testosterone.
- The effect was region‑specific: not all hypothalamic areas responded, indicating certain brain sites mediate kisspeptin’s action on the HPG axis.
Practical Outcomes
- The study confirms that kisspeptin can powerfully stimulate the hormone cascade that produces testosterone, but it required direct brain injections in rats—something not feasible for humans. For biohackers, the main takeaway is that kisspeptin is a potent hormonal activator, yet current delivery methods (e.g., nasal or injectable) are untested for this effect, so it’s not yet a practical protocol for boosting testosterone.
Summary
In male rats, directly injecting the hormone‑like peptide kisspeptin‑54 into specific parts of the brain caused a clear rise in the blood levels of luteinising hormone (LH) and testosterone within an hour, showing that this peptide can strongly activate the reproductive hormone system when it reaches the right brain regions.
Abstract
Kisspeptin-54 is the peptide product of the KiSS-1 gene and an endogenous agonist of the GPR54 receptor. KiSS-1 was initially discovered as a metastasis suppressor gene, but recent studies demonstrate that the kisspeptin/GPR54 system is a key regulator of the reproductive system. Disrupted GPR54 signalling causes hypogonadotrophic hypogonadism in rodents and man. Intracerebroventricular or peripheral administration of kisspeptin potently stimulates the hypothalamic-pituitary-gonadal (HPG) axis via the hypothalamic gonadotrophin-releasing hormone system. We have investigated the effect of injection of kisspeptin-54 into discrete hypothalamic regions on the HPG axis. To construct a dose-response curve for the effects of intrahypothalamic kisspeptin administration, adult male Wistar rats were cannulated into the medial preoptic area (MPOA) at the level of the organum vasculosum laminae terminalis (OVLT). Kisspeptin-54 was injected into the MPOA at doses of 0.01, 0.1, 1, 10 and 100 pmol. At 60 min following injection of 1, 10 or 100 pmol kisspeptin-54, plasma luteinising hormone (LH) and total testosterone levels were significantly increased. Adult male Wistar rats were then cannulated into the rostral preoptic area at the level of the OVLT (RPOA), the MPOA, the paraventricular (PVN), dorsomedial (DMN) and arcuate hypothalamic nuclei, and the lateral hypothalamic area. A dose of 1 pmol kisspeptin-54 was administered into all areas. The circulating levels of LH and total testosterone were significantly increased 60 min postinjection of kisspeptin-54 into the RPOA, MPOA, PVN and arcuate nucleus. Our results suggest that kisspeptin may mediate its effects on the HPG axis via these regions of the hypothalamus.
Study Information
pubmed
2006
2006-05-01T00:00:00.000Z
10.1111/j.1365-2826.2006.01420.x
85
38